IP Library Granted Patent US 10,426,919
Granted Patent B2
US 10,426,919 · App. 16/257,791 · Granted Oct 1, 2019

Systems and methods for inducing negative pressure in a portion of a urinary tract of a patient

Inventors: John R. Erbey, II (Milton, GA); Jacob L. Upperco (Atlanta, GA); David E. Orr (Piedmont, SC); Michael Alan Fisher (Lawrenceville, GA); Patrick William Strane (Atlanta, GA); Lance Michael Black (Pearland, TX)
Assignee: Strataca Systems Limited
A61M25/0017A61F2/04A61M1/0031A61M1/0066A61M25/007A61M25/04A61M25/10A61F2002/048A61F2220/0008A61F2230/0091A61M1/008A61M2205/3303A61M2205/3334A61M2210/1085A61M2210/1089
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,426,919
App. No.
16/257,791
Granted
Oct 1, 2019
Kind
B2
Abstract

Ureteral or bladder catheters are provided, including (a) a proximal portion; and (b) a distal portion, the distal portion including a retention portion that includes one or more protected drainage holes, ports or perforations and is configured to establish an outer periphery or protective surface area that inhibits mucosal tissue from occluding the one or more protected drainage holes, ports or perforations upon application of negative pressure through the catheter. Systems, kits and methods for inducing negative pressure to increase renal function also are provided.

Claims (25)

1. A system for inducing negative pressure in a portion of a urinary tract of a patient, the system comprising:

(a) a ureteral catheter comprising a distal portion configured for insertion within the patient's kidney and a proximal portion;

(b) a bladder catheter comprising a distal portion configured for insertion within the patient's bladder and a proximal portion for application of negative pressure, the proximal portion configured to extend outside of the patient's body; and

(c) a pump external to the patient's body for application of negative pressure through both the bladder catheter and the ureteral catheter, which in turn causes fluid from the kidney to be drawn into the ureteral catheter, through both the ureteral catheter and the bladder catheter, and then outside of the patient's body.

2. The system according to claim 1 , wherein the proximal portion of the ureteral catheter is in fluid communication with the distal portion of the bladder catheter.

3. The system according to claim 1 , wherein the distal portion of the ureteral catheter comprises a retention portion that comprises one or more protected drainage holes, ports or perforations and is configured to establish an outer periphery or protective surface area that inhibits mucosal tissue from occluding the one or more protected drainage holes, ports or perforations upon the application of negative pressure by the pump.

4. The system according to claim 3 , wherein the one or more protected drainage holes, ports or perforations are disposed on a protected surface area or inner surface area of the retention portion of the ureteral catheter, and wherein, upon application of negative pressure, the mucosal tissue conforms or collapses onto the outer periphery or protective surface area of the retention portion of the ureteral catheter and is thereby prevented or inhibited from occluding the one or more of the protected drainage holes, ports or perforations.

5. The system according to claim 1 , wherein the distal portion of the bladder catheter comprises a retention portion that comprises one or more protected drainage holes, ports or perforations and is configured to establish an outer periphery or protective surface area that inhibits mucosal tissue from occluding the one or more protected drainage holes, ports or perforations upon the application of negative pressure by the pump.

6. The system according to claim 5 , wherein the one or more protected drainage holes, ports or perforations are disposed on a protected surface area or inner surface area of the retention portion of the bladder catheter, and wherein, upon application of negative pressure, the mucosal tissue conforms or collapses onto the outer periphery or protective surface area of the retention portion of the bladder catheter and is thereby prevented or inhibited from occluding the one or more of the protected drainage holes, ports or perforations.

7. The system according to claim 1 , further comprising one or more physiological sensors configured to detect at least one physical parameter of the patient.

8. The system according to claim 7 , wherein the at least one physical parameter comprises one or more of volume of urine collected, urine composition, urine protein concentration, blood composition or blood flow.

9. The system according to claim 8 , wherein the at least one physical parameter of blood composition comprises one or more of hematocrit ratio, analyte concentration, protein concentration, or creatinine concentration.

10. The system according to claim 8 , wherein the at least one physical parameter of blood flow comprises one or more of blood pressure or blood flow velocity.

11. The system according to claim 7 , wherein the one or more physiological sensors comprise one or more of pulse oximetry sensor(s), blood pressure sensor(s), heart rate sensor(s), respiration sensor(s), capnography sensor(s), glucose sensor(s), blood velocity sensor(s), hemoglobin sensor(s), hematocrit sensor(s), protein sensor(s), creatinine sensor(s), analyte sensor(s), capacitance sensor(s), optical spectroscopy sensor(s) or combinations thereof.

12. The system according to claim 1 , wherein the pump provides an accuracy of about 10 mmHg or less.

13. The system according to claim 1 , wherein the negative pressure is provided within a range of about 2 mm Hg to about 150 mm Hg.

14. A method for inducing negative pressure in a portion of a urinary tract of a patient, the method comprising:

deploying a ureteral catheter into a ureter of a patient to maintain patency of fluid flow between a kidney and a bladder of the patient, the ureteral catheter comprising a distal portion for insertion within the patient's kidney and a proximal portion;

deploying a bladder catheter into the bladder of the patient, wherein the bladder catheter comprises a distal portion for insertion within the patient's bladder and a proximal portion for application of negative pressure, the proximal portion extending outside of the patient's body; and

applying negative pressure to the proximal end of the bladder catheter to induce negative pressure in a portion of the urinary tract of the patient to remove fluid from the patient.

15. The method according to claim 14 , wherein at least one of the ureteral catheter or the bladder catheter comprises (a) a proximal portion; and (b) a distal portion, the distal portion comprising a retention portion that comprises one or more protected drainage holes, ports or perforations and is configured to establish an outer periphery or protective surface area that inhibits mucosal tissue from occluding the one or more protected drainage holes, ports or perforations upon application of negative pressure through the catheter.

16. The method according to claim 14 , wherein the ureteral catheter is deployed and remains in the patient's body for at least 24 hours.

17. The method according to claim 14 , wherein the ureteral catheter is deployed and remains in the patient's body for at least 30 days or longer.

18. The method according to claim 14 , wherein the bladder catheter is replaced more often that the ureteral catheter.

19. The method according to claim 14 , wherein multiple bladder catheters are placed and removed during the indwell time for a single set of ureteral catheters.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY INTERNAL ADDRESS PREVIOUSLY RECORDED AT REEL: 057647 FRAME: 0601. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 22, 2022
From: STRATACA SYSTEMS, LTD.
To: ROIVIOS LIMITED
Reel/Frame 059279/0434 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2021
From: STRATACA SYSTEMS LTD.
To: ROIVIOS LIMITED
Reel/Frame 057647/0601 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2019
From: ERBEY, JOHN R., II; UPPERCO, JACOB L.; ORR, DAVID E.; FISHER, MICHAEL ALAN; STRANE, PATRICK WILLIAM; BLACK, LANCE MICHAEL
To: STRATACA SYSTEMS LIMITED
Reel/Frame 048302/0447 →
Continuity (16)
Continuation 16205987 · Nov 30, 2018
Continuation In Part 15879770 · Jan 25, 2018
Continuation In Part 15687064 · Aug 25, 2017
Continuation In Part 15411884 · Jan 20, 2017
Continuation In Part 15214955 · Jul 20, 2016
Continuation In Part 15687083 · Aug 25, 2017
Continuation In Part 15411884
Continuation In Part 15214955
Continuation In Part 15745823
Provisional Application 62300025 · Feb 25, 2016
Provisional Application 62278721 · Jan 14, 2016
Provisional Application 62260966 · Nov 30, 2015
Provisional Application 62194585 · Jul 20, 2015
Provisional Application 62489789 · Apr 25, 2017
Provisional Application 62489831 · Apr 25, 2017
Related Publication 20190167944A1 · Jun 6, 2019
Cited By (9)
US 12,214,117 US 12,226,603 US 12,318,552 US 12,420,005 US 12,491,103 US 12,636,208 US 12,678,587 US 12,697,426 US 12,708,302